At a glance
ClinicalIndex Comparison RecordN/ACompleted· 202 enrolled
Drug / intervention
Percutaneous coronary interventiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
6 Months Evaluation of the BIOTRONIK PRO-Kinetic Coronary Stent System
In Brief
A clinical study evaluating Percutaneous coronary intervention for Coronary Artery Disease. Completed, enrolled 202 participants.
Detailed Summary
The primary objective of this study is to evaluate safety and efficacy of the BIOTRONIK PRO-Kinetic coronary CoCr-stent in patients with single de novo lesions of native coronary arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2007
Primary CompletionApr 2008
Study CompletionMar 2009
First PostedFeb 2012
TodayJul 2026
First PostedFeb 13, 2012
Enrollment StartFeb 1, 2007
Primary CompletionApr 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.4 years ago
Interventions
Percutaneous coronary interventiondevice
Percutaneous coronary intervention